Acting Commissioner Von Eschenbach and others testified about the proposed fiscal year 2007 budget for the Food and Drug Administration. Topics included the rapid development of safer, more effective life-saving drugs, biologics, and medical devices. Other topics included vaccines for a possible avian flu pandemic, mad cow disease, and the dangers of cutting funding.